Antagonism of CD11b with Neutrophil Inhibitory Factor (NIF) Inhibits Vascular Lesions in Diabetic Retinopathy

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Veenstra, Alexander A ^a   Tang, Jie ^a   Kern, Timothy S ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; NEUTROPHIL INHIBITORY FACTOR; SUPEROXIDE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; CELL ISOLATION; CONTROLLED STUDY; DEGENERATION; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; HISTOPATHOLOGY; IMMUNE SYSTEM; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LEUKOSTASIS; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RETINA; RETINA CAPILLARY; STREPTOZOCIN DIABETES; VASCULAR LESION; WILD TYPE; ANIMAL; CAPILLARY; CELL ADHESION; CHEMICALLY INDUCED; EXPERIMENTAL DIABETES MELLITUS; LEUKOCYTE; METABOLISM; NEUTROPHIL; PHYSIOLOGY; RETINA BLOOD VESSEL; RETINA DEGENERATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD11B; CAPILLARIES; CELL ADHESION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; LEUKOCYTES; LEUKOSTASIS; MACROPHAGE-1 ANTIGEN; MALE; MICE; NEUTROPHILS; RETINA; RETINAL DEGENERATION; RETINAL VESSELS; STREPTOZOCIN; SUPEROXIDES;

EID: 84886870592     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078405     Document Type: Article

References (47)

1. Ding J, Wong TY, (2012) Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 12: 346-354. doi:10.1007/s11892-012-0283-6. PubMed: 22585044.
2. Frank RN, (2011) Importance of the NHANES 2005-2008 diabetic retinopathy data. Arch Ophthalmol 129: 788-790. doi:10.1001/archophthalmol.2011.125. PubMed: 21670347.
3. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, et al. (2010) Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 304: 649-656. doi:10.1001/jama.2010.1111. PubMed: 20699456.
4. Bresnick GH, Engerman R, Davis MD, de Venecia G, Myers FL, (1976) Patterns of ischemia in diabetic retinopathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 81: OP694-709. PubMed: 822560.
5. Engerman RL, (1976) Animal models of diabetic retinopathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 81: OP710-715.
6. DCCT (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986. doi:10.1056/NEJM199309303291401. PubMed: 8366922.
7. Klein R, Klein BE, Moss SE, Cruickshanks KJ, (1994) Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154: 2169-2178. doi:10.1001/archinte.154.19.2169. PubMed: 7944837.
8. Schröder S, Palinski W, Schmid-Schönbein GW, (1991) Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 139: 81-100. PubMed: 1713023.
9. McLeod DS, Lefer DJ, Merges C, Lutty GA, (1995) Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147: 642-653. PubMed: 7545873.
10. Chibber R, Ben-Mahmud BM, Chibber S, Kohner EM, (2007) Leukocytes in diabetic retinopathy. Curr. Diabetes Rev 3: 3-14. doi:10.2174/157339907779802139.
11. Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, et al. (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A 96: 10836-10841. doi:10.1073/pnas.96.19.10836. PubMed: 10485912.
12. Takahashi K, Kishi S, Muraoka K, Shimizu K, (1998) Reperfusion of occluded capillary beds in diabetic retinopathy. Am J Ophthalmol 126: 791-797. doi:10.1016/S0002-9394(98)00242-6. PubMed: 9860002.
13. Li G, Veenstra AA, Talahalli RR, Wang X, Gubitosi-Klug RA, et al. (2012) Marrow-Derived Cells Regulate the Development of Early Diabetic Retinopathy and Tactile Allodynia in Mice. Diabetes 61: 3294-3303. doi:10.2337/db11-1249. PubMed: 22923475.
14. Kishimoto TK, Larson RS, Corbi AL, Dustin ML, Staunton DE, et al. (1989) The leukocyte integrins. Adv Immunol 46: 149-182. doi:10.1016/S0065-2776(08)60653-7. PubMed: 2551146.
15. Lum H, Gibbs L, Lai L, Malik AB, (1994) CD18 integrin-dependent endothelial injury: effects of opsonized zymosan and phorbol ester activation. J Leukoc Biol 55: 58-63. PubMed: 7904295.
16. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, et al. (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158: 147-152. doi:10.1016/S0002-9440(10)63952-1. PubMed: 11141487.
17. Barouch FC, Miyamoto K, Allport JR, Fujita K, Bursell SE, et al. (2000) Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 41: 1153-1158. PubMed: 10752954.
18. Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, et al. (2005) Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 46: 1440-1444. doi:10.1167/iovs.04-0905. PubMed: 15790913.
19. Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, et al. (2007) Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci 48: 858-865. doi:10.1167/iovs.06-0495. PubMed: 17251488.
20. Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS, (2007) Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 56: 337-345. doi:10.2337/db06-0789. PubMed: 17259377.
21. Ustinov VA, Plow EF, (2002) Delineation of the key amino acids involved in neutrophil inhibitory factor binding to the I-domain supports a mosaic model for the capacity of integrin alphaMbeta 2 to recognize multiple ligands. J Biol Chem 277: 18769-18776. doi:10.1074/jbc.M110242200. PubMed: 11880366.
22. Barnard JW, Biro MG, Lo SK, Ohno S, Carozza MA, et al. (1995) Neutrophil inhibitory factor prevents neutrophil-dependent lung injury. J Immunol 155: 4876-4881. PubMed: 7594491.
23. Rieu P, Ueda T, Haruta I, Sharma CP, Arnaout MA, (1994) The A-domain of beta 2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived neutrophil adhesion inhibitor NIF. J Cell Biol 127: 2081-2091. doi:10.1083/jcb.127.6.2081. PubMed: 7528750.
24. Zhang L, Plow EF, (1996) Overlapping, but not identical, sites are involved in the recognition of C3bi, neutrophil inhibitory factor, and adhesive ligands by the alphaMbeta2 integrin. J Biol Chem 271: 18211-18216. doi:10.1074/jbc.271.30.18211. PubMed: 8663418.
25. Gao XP, Liu Q, Broman M, Predescu D, Frey RS, et al. (2005) Inactivation of CD11b in a mouse transgenic model protects against sepsis-induced lung PMN infiltration and vascular injury. Physiol Genomics 21: 230-242. doi:10.1152/physiolgenomics.00291.2004. PubMed: 15831844.
26. Zheng L, Du Y, Miller C, Gubitosi-Klug RA, Kern TS, et al. (2007) Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50: 1987-1996. doi:10.1007/s00125-007-0734-9. PubMed: 17583794.
27. Kern TS, Miller CM, Du Y, Zheng L, Mohr S, et al. (2007) Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56: 373-379. doi:10.2337/db05-1621. PubMed: 17259381.
28. Zheng L, Du Y, Miller C, Gubitosi-Klug RA, Ball S, et al. (2007) Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50: 1987-1996. doi:10.1007/s00125-007-0734-9. PubMed: 17583794.
29. Du Y, Miller CM, Kern TS, (2003) Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 35: 1491-1499. doi:10.1016/j.freeradbiomed.2003.08.018. PubMed: 14642397.
30. Laver NM, Robison WG Jr, Pfeffer BA, (1993) Novel procedures for isolating intact retinal vascular beds from diabetic humans and animal models. Invest Ophthalmol Vis Sci 34: 2097-2104. PubMed: 8491560.
31. Kern TS, Mohr S, (2007) Nonproliferative stages of diabetic retinopathy: animal models and pathogenesis. In: Joussen A, Gardner TW, Kirchof B, Ryan SJ, eds. Retinal Vascular Disease. Springer Verlag.
32. Su X, Sorenson CM, Sheibani N, (2003) Isolation and characterization of murine retinal endothelial cells. Mol Vis 9: 171-178. PubMed: 12740568.
33. Van Ziffle JA, Lowell CA, (2009) Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection. Blood 114: 4871-4882. doi:10.1182/blood-2009-05-220806. PubMed: 19797524.
34. Kamen LA, Schlessinger J, Lowell CA, (2011) Pyk2 is required for neutrophil degranulation and host defense responses to bacterial infection. J Immunol 186: 1656-1665. doi:10.4049/jimmunol.1002093. PubMed: 21187437.
35. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, et al. (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18: 1450-1452. PubMed: 15231732.
36. Pei Tian HG, Liu H, Kern TS, Du L, Guan L, (2013) Leukocytes from diabetic patients kill retinal endothelial cells: effects of berberine. Mol Vis (In press).
37. Simon DI, (2011) Opening the field of integrin biology to "biased agonism". Circ Res 109: 1199-1201. doi:10.1161/CIRCRESAHA.111.257980. PubMed: 22076504.
38. Ohno S, Malik AB, (1997) Polymorphonuclear leucocyte (PMN) inhibitory factor prevents PMN-dependent endothelial cell injury by an anti-adhesive mechanism. J Cell Physiol 171: 212-216. doi:10.1002/(SICI)1097-4652(199705)171:2. PubMed: 9130469.
39. Moyle M, Foster DL, McGrath DE, Brown SM, Laroche Y, et al. (1994) A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18. J Biol Chem 269: 10008-10015. PubMed: 7908286.
40. Major EO, (2010) Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61: 35-47. doi:10.1146/annurev.med.080708.082655. PubMed: 19719397.
41. Uettwiller F, Rigal E, Hoarau C, (2011) Infections associated with monoclonal antibody and fusion protein therapy in humans. MAbs 3: 461-466. doi:10.4161/mabs.3.5.16553. PubMed: 21822056.
42. Bowen JD, Petersdorf SH, Richards TL, Maravilla KR, Dale DC, et al. (1998) Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis. Clin Pharmacol Ther 64: 339-346. doi:10.1016/S0009-9236(98)90183-7. PubMed: 9757158.
43. EAST (2001) Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 57: 1428-1434. doi:10.1212/WNL.57.8.1428. PubMed: 11673584.
44. Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo JM, et al. (2003) Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 34: 2543-2548. doi:10.1161/01.STR.0000092527.33910.89. PubMed: 14563972.
45. Zhang L, Zhang ZG, Zhang RL, Lu M, Krams M, et al. (2003) Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke 34: 1790-1795. doi:10.1161/01.STR.0000077016.55891.2E. PubMed: 12805500.
46. Faridi MH, Altintas MM, Gomez C, Duque JC, Vazquez-Padron RI, et al. (2013) Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury. Biochim Biophys Acta 1830: 3696-3710. doi:10.1016/j.bbagen.2013.02.018. PubMed: 23454649.
47. Ali F, Brown A, Stanssens P, Timothy LM, Soule HR, et al. (2001) Vaccination with neutrophil inhibitory factor reduces the fecundity of the hookworm Ancylostoma ceylanicum. Parasite Immunol 23: 237-249. doi:10.1046/j.1365-3024.2001.00383.x. PubMed: 11309134.